Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine

被引：0
|
作者：
Daniel C. Moreira
Sujatha Venkataraman
Apurva Subramanian
John Desisto
Ilango Balakrishnan
Eric Prince
Angela Pierce
Andrea Griesinger
Adam Green
Charles G. Eberhardt
Nicholas K. Foreman
Rajeev Vibhakar
机构：
[1] University of Colorado Anschutz Medical Campus,Department of Pediatrics
[2] Children’s Hospital Colorado,Morgan Adams Foundation Pediatric Brain Tumor Research Program
[3] University of Colorado Denver,Department of Neurosurgery
[4] Johns Hopkins University,Department of Pathology, School of Medicine
[5] St. Jude Children’s Research Hospital,Department of Oncology
来源：
Journal of Neuro-Oncology | 2020年 / 147卷
关键词：
MYC; Replication stress; Medulloblastoma; AZD1775; Gemcitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：531 / 545
页数：14
相关论文
共 50 条
  • [41] SYNERGISM OF HDAC AND PARP INHIBITORS IN MYC-DRIVEN GROUP 3 MEDULLOBLASTOMA CELLS
    Vollmer, Johanna
    Ecker, Jonas
    Hielscher, Thomas
    Valinciute, Gintvile
    Oppermann, Sina
    Peterziel, Heike
    Oehme, Ina
    Witt, Olaf
    Milde, Till
    NEURO-ONCOLOGY, 2020, 22 : 401 - 401
  • [42] Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma
    Nagendra K. Chaturvedi
    Sidharth Mahapatra
    Varun Kesherwani
    Matthew J. Kling
    Mamta Shukla
    Sutapa Ray
    Ranjana Kanchan
    Naveenkumar Perumal
    Timothy R. McGuire
    J. Graham Sharp
    Shantaram S. Joshi
    Don W. Coulter
    BMC Cancer, 19
  • [43] In vivo metabolomics reveals a potentially potent combination therapy for MYC-driven medulloblastoma
    Hanaford, Allison R.
    Poore, Brad
    Alt, Jesse
    Slusher, Barbara
    Eberhart, Charles G.
    Raabe, Eric H.
    CANCER RESEARCH, 2018, 78 (13)
  • [44] LATENT SOX9-POSITIVE CELLS BEHIND MYC-DRIVEN MEDULLOBLASTOMA
    Borgenvik, Anna
    Bolin, Sara
    Savov, Vasil
    Holmberg, Karl O.
    Zhao, Miao
    Rosen, Gabriela
    Hutter, Sonja
    Garancher, Alexandra
    Rahmanto, Aldwin Suryo
    Bergstrom, Tobias
    Mainwaring, Oliver
    Sattanino, Damiana
    Verbaan, Annemieke D.
    Rusert, Jessica
    Sundstrom, Anders
    Dang, Yonglong
    Wenz, Amelie
    Richardson, Stacey
    Fotaki, Grammatiki
    Giraud, Geraldine
    Hill, Rebecca
    Dubuc, Adrian
    Kalushkova, Antonia
    Remke, Marc
    Cancer, Matko
    Jernberg-Wiklund, Helena
    Chen, Xingqi
    Taylor, Michael D.
    Sangfelt, Olle
    Clifford, Steven
    Schuller, Ulrich
    Wechsler-Reya, Robert
    Weishaupt, Holger
    Swartling, Fredrik
    NEURO-ONCOLOGY, 2021, 23 : 220 - 221
  • [45] Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells
    D Kawauchi
    R J Ogg
    L Liu
    D J H Shih
    D Finkelstein
    B L Murphy
    J E Rehg
    A Korshunov
    C Calabrese
    F Zindy
    T Phoenix
    Y Kawaguchi
    J Gronych
    R J Gilbertson
    P Lichter
    A Gajjar
    M Kool
    P A Northcott
    S M Pfister
    M F Roussel
    Oncogene, 2017, 36 : 5231 - 5242
  • [46] PLK1 INHIBITION IN COMBINATION WITH STANDARD THERAPIES FOR MYC-DRIVEN MEDULLOBLASTOMA
    Balakrishnan, Ilango
    Venkataraman, Sujatha
    Pierce, Angela M.
    Alimova, Irina
    Prince, Eric
    Moreira, Daniel C.
    Fosmire, Susan
    Madhavan, Krishna
    Foreman, Nicholas
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2017, 19 : 44 - 44
  • [47] CDK9 IS A DRUGGABLE MEDIATOR SUSTAINING MYC-DRIVEN CIRCUITRY IN MEDULLOBLASTOMA
    Madhavan, Krishna
    Walker, Faye
    Wang, Dong
    Sobral, Lays Martin
    Balakrishnan, Ilango
    Pierce, Angela
    Serkova, Natalie
    Foreman, Nicholas
    Venkataraman, Sujatha
    Vibhakar, Rajeev
    Dahl, Nathan
    NEURO-ONCOLOGY, 2022, 24 : 111 - 111
  • [48] Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma
    Chaturvedi, Nagendra K.
    Mahapatra, Sidharth
    Kesherwani, Varun
    Kling, Matthew J.
    Shukla, Mamta
    Ray, Sutapa
    Kanchan, Ranjana
    Perumal, Naveenkumar
    McGuire, Timothy R.
    Sharp, J. Graham
    Joshi, Shantaram S.
    Coulter, Don W.
    BMC CANCER, 2019, 19 (01)
  • [49] Targeting RNA polymerase I to treat MYC-driven cancer
    G Poortinga
    L M Quinn
    R D Hannan
    Oncogene, 2015, 34 : 403 - 412
  • [50] Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
    Sara Bolin
    Anna Borgenvik
    Camilla U. Persson
    Anders Sundström
    Jun Qi
    James E. Bradner
    William A. Weiss
    Yoon-Jae Cho
    Holger Weishaupt
    Fredrik J. Swartling
    Oncogene, 2018, 37 : 2850 - 2862
12345